Emyria

D4, 661 Newcastle Street
Leederville WA 6007

Corporate Governance

Annual Reports

Share Price

Announcements

New investors

Why Invest in Emyria?

Investor Research

Loyalty Option Offer

About Emyria

Home

Successes

Meet the Team

Contact Us

Updates

Montserrat

Emyria Limited

Receiving a cancer diagnosis can cause immense psychological distress for patients already managing the physical and emotional challenges of their illness. Emyria’s Empax Centre is proud to be at the forefront of research exploring new ways to support these patients by leading a clinical trial funded by Psyence Biomed.

Empax was selected as the lead site given our extensive experience delivering complex, multidisciplinary mental health care under rigorous clinical governance.

The trial will investigate the potential of psilocybin-assisted therapy to help individuals process their diagnosis and find peace during periods of profound uncertainty and is aiming to enrol 87 participants.

Recently, 9News Perth visited the Empax Centre to report on the study, featuring the story of Meagan Appelbee, a 44-year-old nurse living with advanced triple negative breast cancer, who describes maintaining a positive outlook as “half the battle.”

Interested in participating or learning more?

If you, or a loved one is struggling psychologically with a cancer diagnosis you can find out more about this trial by emailing  info@empaxcentre.com.

Empax Centre Leading National Clinical Trial into Psilocybin-Assisted Therapy for Cancer-Related Emotional Distress